About Zaire Ebola Virus Glycoprotein (GP)

Zaire ebolavirus is the most pathogenic species of the Ebola virus genus and has been responsible for multiple outbreaks of severe Ebola virus disease. The viral glycoprotein (GP) is the only surface protein expressed on the Ebola virion and plays a critical role in host-cell attachment, receptor interaction, membrane fusion, and viral entry. Because GP is exposed on the viral surface and directly mediates infection, it serves as the primary target of protective immune responses, neutralizing antibodies, vaccine development programs, and antiviral therapeutic strategies.

The Ebola virus glycoprotein is one of the most extensively studied viral antigens in infectious disease research. Numerous studies have demonstrated that antibodies targeting GP can effectively neutralize viral infection and provide protection against disease. The licensed rVSV-ZEBOV Ebola vaccine utilizes the Zaire Ebola virus glycoprotein as its immunogenic target, highlighting the importance of GP in vaccine-induced immunity and outbreak prevention. In addition, several approved and investigational monoclonal antibody therapies target Ebola GP to block viral entry and infection.

eEnzyme's recombinant Zaire Ebola Virus Glycoprotein is expressed in mammalian cells and provides a valuable research tool for vaccine development, antibody screening, viral entry studies, receptor-binding investigations, structural biology research, and immunological assay development. Researchers can utilize this recombinant antigen to characterize neutralizing antibody responses, investigate mechanisms of Ebola virus infection, and support the development of next-generation vaccines and therapeutic antibodies.

Applications of Zaire Ebola Virus Glycoprotein

• Neutralizing antibody discovery and characterization
• Ebola vaccine development and evaluation
• Viral attachment and entry studies
• Receptor-binding investigations
• Structural biology and epitope mapping
• ELISA, Western blot, and immunological assays

Biological Significance of Ebola Virus Glycoprotein

The Ebola virus glycoprotein functions as the primary mediator of viral entry into host cells and is essential for infection. During the viral life cycle, GP facilitates host-cell attachment, intracellular trafficking, and membrane fusion, ultimately allowing delivery of the viral genome into the host cell. Because GP contains the major neutralizing epitopes recognized by protective antibodies and serves as the foundation of current Ebola vaccine platforms, it remains one of the most important targets for vaccine research, therapeutic antibody development, and antiviral countermeasure discovery. Studies of Ebola survivors and vaccinated individuals consistently demonstrate strong immune responses directed against GP, further supporting its central role in protective immunity.